GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Gross Profit

Embla Medical hf (OCSE:EMBLA) Gross Profit : kr3,402 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Gross Profit?

Embla Medical hf's gross profit for the three months ended in Mar. 2024 was kr826 Mil. Embla Medical hf's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was kr3,402 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Embla Medical hf's gross profit for the three months ended in Mar. 2024 was kr826 Mil. Embla Medical hf's Revenue for the three months ended in Mar. 2024 was kr1,371 Mil. Therefore, Embla Medical hf's Gross Margin % for the quarter that ended in Mar. 2024 was 60.26%.

Embla Medical hf had a gross margin of 60.26% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Embla Medical hf was 63.92%. The lowest was 61.19%. And the median was 62.91%.


Embla Medical hf Gross Profit Historical Data

The historical data trend for Embla Medical hf's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Gross Profit Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,949.00 2,392.56 2,996.90 3,088.31 3,318.79

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 778.99 865.48 831.75 878.61 826.16

Competitive Comparison of Embla Medical hf's Gross Profit

For the Medical Devices subindustry, Embla Medical hf's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Gross Profit distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Gross Profit falls into.



Embla Medical hf Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Embla Medical hf's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=5369.986 - 2051.192
=3,319

Embla Medical hf's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=1370.945 - 544.785
=826

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,402 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Embla Medical hf's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=826 / 1370.945
=60.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Embla Medical hf  (OCSE:EMBLA) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Embla Medical hf had a gross margin of 60.26% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Embla Medical hf Gross Profit Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines